[EATG Global HIV News daily digest] Digest #186-2009

[EATG Global HIV News daily digest]

Global HIV News Daily Digest

Copied as fair use  -  Ana  -





Latest Headlines




  Ecuador’s Presidential declaration on access to medicines and compulsory licensing
  Access to treatment Wednesday 28 October 2009
					
  
The declaration opens the door to competition of generic medicines with
patented brand-name drugs, through use of an internationally recognized
legal mechanism called compulsory licensing. 
  




  HIV drug patents in the spotlight
  Access to treatment Wednesday 28 October 2009
					
  
Although companies are increasingly instituting their own initiatives
to increase access, calls for the pharmaceutical industry to join the
UNITAID patent pool have grown louder. 
  SOURCE:
The Lancet




  Vertex loss grows on increased development costs
  Pharma Industry Wednesday 28 October 2009
					
  
Vertex Pharmaceuticals Inc. reported a larger third-quarter loss on
Monday, as revenue fell and the company spent more money to support the
launch of its hepatitis C drug candidate.
  SOURCE:
AP




  Industry years behind on testing approved drugs 
  EMEA & FDA Wednesday 28 October 2009
					
  
Federal drug officials have long been criticized for failing to force
drug makers to complete studies proving that their drugs work as hoped,
and Congressional investigators on Monday released yet another report
pointing out that some of these studies remain undone many years after
being promised.
  SOURCE:
The New York Times




  Combating HIV/AIDS remains a public health concern and political priority for Europe
  EU Policy Wednesday 28 October 2009
					
  
The EU HIV/AIDS Civil Society Forum welcomes the new EU strategy for
combating HIV/AIDS in the EU and neighbouring countries 2009-2013
published by the Commission yesterday.
  SOURCE:
EATG




  Scientists use world's fastest supercomputer to create the largest HIV evolutionary tree
  Basic Science Wednesday 28 October 2009
					
  
Supporting Los Alamos National Laboratory's role in the international
Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers
are using the Roadrunner supercomputer to analyze vast quantities of
genetic sequences from HIV infected people in the hope of zeroing in on
possible vaccine target areas.
  SOURCE:
ScienceDaily




  U.S. aid saves lives but few know, Bill Gates says
  World Policy Wednesday 28 October 2009
					
  
Money spent on AIDS, malaria, vaccines pays off; Gates said bipartisan effort needs thanks; Website will tell success stories.
  SOURCE:
REUTERS




  Ranbaxy profits up but US sales still suffering
  Pharma Industry Wednesday 28 October 2009
					
  
Ranbaxy has reported net income of 1.17 billion rupees, or around $24
million, for the third quarter, up from a 3.90 billion rupee loss in
the like, year-earlier period, helped by cost-cutting.
  SOURCE:
PharmaTimes




  Federal study would test all adults in a community for AIDS
  Prevention Wednesday 28 October 2009
					
  
Federal health officials are preparing a plan to study a bold new
strategy to stop the spread of the AIDS virus: routinely testing
virtually every adult in a community, and promptly treating those found
to be infected. The strategy is called 'test and treat'.
  SOURCE:
The Medical News




  HIV infections, deaths declining in Caribbean, senior official says
  Epidemiology Wednesday 28 October 2009
					
  
There were a recorded 17,000 new infections last year compared to
20,000 the previous year and 11,000 deaths compared to 14,000 during
the same period.
  SOURCE:
The Medical News




  ZymoGenetics initiates Phase 2 clinical trial of PEG-Interferon lambda in hepatitis C with Bristol-Myers Squibb
  Hepatitis Wednesday 28 October 2009
					
  
PEG-Interferon lambda is a targeted type 3 interferon in development for hepatitis C.
  SOURCE:
ZymoGenetics, Inc.




  Crestor reduces lipids better than Pravachol in people with HIV
  Treatment Wednesday 28 October 2009
					
  
Crestor is superior to Pravachol in reducing both LDL and
triglycerides. Longer-term studies should be carried out to determine
whether it improves health problems associated with cardiovascular
disease, such as heart attacks and strokes.
  SOURCE:
AIDSmeds.com




  Brief shocks may deliver AIDS vaccines better: study
  Prevention Wednesday 28 October 2009
					
  
Brief electric shocks may help the body better respond to certain kinds of experimental AIDS vaccines.
  SOURCE:
Medscape Today




  Russia urged to expand prevention for injecting drug users 
  Prevention Wednesday 28 October 2009
					
  
As Moscow prepares to host the 3rd Eastern Europe and Central Asia AIDS
Conference (EECAAC) on 28–30 October, the Eurasian Harm Reduction
Network, the International AIDS Society and the International Harm
Reduction Association have issued a joint call to the Russian
Government to dramatically expand access to HIV prevention programmes
for people who inject drugs. 
  SOURCE:
Aidsmap




  CDC approves the removal of US HIV travel ban 
  World Policy Wednesday 28 October 2009
					
  
The Office of Budget and Management has up to 60 days to respond to the
CDC’s approval. Once this has been granted, the travel ban will be
finally removed. 
  SOURCE:
Aidsmap




  Hepatitis C coinfection doesn't increase risk of progression to AIDS 
  Hepatitis Wednesday 28 October 2009
					
  
A meta-analysis of over 30 studies involving in excess of 100,000
patients with HIV has shown that hepatitis C co-infection does not
increase the risk of progression to AIDS. 
  SOURCE:
Aidsmap




  Meeting to consider UK ban on gay blood donations 
  MSM Wednesday 28 October 2009
					
  
Gay men are far from being the only group who are excluded from giving blood on either a permanent or temporary basis.
  SOURCE:
Aidsmap




  HIV transmission through injecting drug use on the increase in the UK 
  Epidemiology Wednesday 28 October 2009
					
  
HIV transmission among injecting drug users is happening more often now
than at the beginning of the decade, the Health Protection Agency says
in a report issued this week. 
  SOURCE:
Aidsmap


----------------------------------------------------

DISCLAIMER
The articles in this digest represent a diversity of opinions on topics
of interest to the HIV treatment activist community. The EATG is not
responsible for their content. The articles posted in this digest do
not necessarily reflect EATG views or opinions.
FAIR USE NOTICE
The digest may contain copyrighted material which has not always been
specifically authorised by the copyright owner. Such material is made
available for educational purposes to advance the understanding of
scientific, ethical, legal and social issues. It is believed that this
constitutes a 'fair use' of any such copyrighted material. This
material is distributed without profit.


 

Information in this digest was accurately quoted during its compilation.



  





      
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.eatg.org/pipermail/eatg-forum_eatg.org/attachments/20091028/36a04663/attachment-0001.html>